Translate this page into:
Adult-onset melanonychia in Indian patients: A comprehensive narrative review
*Corresponding author: Vishal Gaurav, Department of Dermatology and Venereology, All India Institute of Medical Sciences-Central Armed Police Forces Institute of Medical Sciences, New Delhi, India. mevishalgaurav@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Mathur D, Grover C, Gaurav V. Adult-onset melanonychia in Indian patients: A comprehensive narrative review. J Onychol Nail Surg. 2025;2:76-87. doi: 10.25259/JONS_29_2025
Abstract
Melanonychia, defined as a brown-to-black pigmentation of the nail apparatus, most frequently presents as a longitudinal band (melanonychia striata), although diffuse (total) or transverse presentations also occur. This pigmentation results from either melanocytic activation or proliferation. Although frequently benign, melanonychia may also be the first sign of subungual melanoma (SUM). In Indian skin, melanonychia (racial/ethnic) is relatively common; however, there is an increasing concern amongst patients regarding the possibility of a malignancy. This review provides a detailed analysis of adult-onset melanonychia in Indian patients, highlighting its aetiology, clinical and onychoscopic features, diagnostic approach, histopathology, molecular genetics, management and prognosis in the Indian context. It includes a narrative synthesis of published literature, including Indian case series and other published literature, while focusing on coloured skin. In Indian adults (pigmented skin types), benign longitudinal melanonychia, often constitutional or reactive, is common; however, SUM, though rare, remains a serious differential. Diagnosis must integrate history, complete nail examination, onychoscopy, photographic monitoring and a low threshold for nail-matrix biopsy in suspicious cases. Molecular profiling indicates that SUM in Asian populations often harbours KIT (KIT proto-oncogene, receptor tyrosine kinase) or guanine nucleotide-binding protein, alpha Q polypeptide (GNAQ) mutations rather than the classical BRAF/NRAS (v-raf murine sarcoma viral oncogene homolog B/ neuroblastoma RAS viral oncogene homolog) mutations seen in sun-exposed melanomas. While the majority of melanonychia in Indian adults is benign, careful evaluation and awareness of red-flag features are essential to permit an early detection of melanoma. A structured diagnostic algorithm and clinician awareness are important for efficient management.
Keywords
Dermoscopy
India
Longitudinal melanonychia
Melanonychia
Nail-matrix biopsy
Subungual melanoma
INTRODUCTION
Melanonychia, derived from the Greek words melas (black) and onyx (nail), refers to brown-to-black pigmentation of the nail plate or nail unit, resulting from melanin deposition within the nail keratin.[1,2] The condition most commonly manifests as a longitudinal pigmented band (melanonychia striata), though diffuse or transverse pigmentation may also occur.[2,3] This pigmentation arises either from melanocytic activation (increased melanin synthesis by a normal number of melanocytes) or melanocytic hyperplasia (increase in melanocyte number, benign or malignant).[1,4]
While melanonychia may be mostly benign, particularly amongst individuals with darker Fitzpatrick skin types, its clinical relevance stems from the fact that it may be the earliest sign of subungual melanoma (SUM).[5,6] Globally, SUM accounts for only 0.7–3.5% of all melanomas, yet it is proportionally more frequent in Asian, African and Hispanic populations and often presents at an advanced stage due to diagnostic delays.[6-8]
In Indian adults, constitutional and reactive melanonychia (secondary to ethnicity, trauma, inflammation or drugs) is frequently observed.[9,10] However, delayed recognition of SUM remains a concern, with reported cases being often diagnosed at advanced or metastatic stages.[11,12] A cultural aversion to nail biopsy, limited access to onychoscopy, and overlapping benign clinical patterns in pigmented skin contribute to this underdiagnosis.[9,12,13]
Understanding the epidemiology, clinical features and onychoscopic patterns of melanonychia in Indian patients is crucial towards guiding a timely diagnosis and management.
Moreover, emerging molecular data suggest that SUM in Asian populations often harbours KIT (KIT protooncogene, receptor tyrosine kinase) or GNAQ (guanine nucleotide-binding protein, alpha Q polypeptide) mutations rather than the classical BRAF/NRAS (v-raf murine sarcoma viral oncogene homolog B/ neuroblastoma RAS viral oncogene homolog) alterations seen in sun-exposed melanomas, underscoring its distinct pathogenesis and therapeutic implications.[14-16] This review aims to provide a comprehensive synthesis of adult-onset melanonychia in Indian patients, encompassing its etiopathogenesis, clinical and onychoscopic features, histopathologic and molecular findings, diagnostic approach and management strategies, integrating Indian case series with global evidence.
METHODOLOGY
This narrative review focuses on adult patients with melanonychia, with particular emphasis on data from Indian patients and comparison with global literature. A comprehensive search was conducted in PubMed, Embase, Scopus and Web of Science (2000–2025) using the terms ‘melanonychia’, ‘longitudinal melanonychia’, ‘nail melanoma’, ‘onychoscopy’, ‘nail pigmentation’ and ‘India’. Reference lists were also screened. Articles were included if they reported on adult patients (≥18 years) with melanonychia or nail-unit melanoma (NUM) and contained clinical, onychoscopic, histopathologic or molecular details. Paediatric-only studies, editorials and abstracts without full text were excluded. Given the heterogeneity of data (mostly case reports and small series), findings were synthesised narratively.
EPIDEMIOLOGY
Global context
The prevalence and clinical presentation of adult-onset melanonychia vary substantially with the ethnic background, phototype and environmental factors. It is significantly more common in individuals with darker Fitzpatrick skin types (IV-VI), where racial or constitutional melanonychia represents a physiologic phenomenon due to an increased basal melanocyte activity within the nail matrix.[17,18]
In Caucasians, longitudinal melanonychia (LM) occurs in approximately 1% of adults, usually as a solitary band that warrants evaluation for melanoma. In contrast, the prevalence rises to 10–20% in East Asian populations, reaching 70–90% amongst individuals of African descent, where it may become nearly universal after the fifth decade.[1,19] The condition typically affects multiple nails, most often the thumbs and index fingers and the pigment bands may gradually widen or darken with age. Referral studies from tertiary nail clinics suggest that LM accounts for 1–5% of all nail consultations. However, the true population burden is likely underestimated due to variability in reporting and diagnostic thresholds.[1,5] Recent international analyses indicate that NUM constitutes only 0.7–3.5% of all melanomas, yet its relative frequency is higher in Asian, Hispanic and African populations, often involving acral and subungual sites.[20,21]
Indian context
India currently lacks robust epidemiologic or registry-based data on melanonychia. However, hospital-based studies and clinical experience suggest that benign LM (constitutional, traumatic or inflammatory) is frequently encountered in Indian dermatology and nail clinics.[3,11] For example, a series from India described four Indian patients (three women, one man) over 2.5 years with SUM of the great toe; half already had metastases on presentation.[11,19] This implies significant delay or under-recognition. Cultural factors (reluctance for nail-unit biopsy, cosmetic concern about nail-loss), limited access to onychoscopy in many centres, and misattribution to onychomycosis/trauma may contribute to underreporting.[22,23] For Indian clinicians, an awareness that pigmented nail bands are standard in pigmented skin, but still require scrutiny, is vital.
PATHOGENESIS
Longitudinal melanonychia results from two fundamental mechanisms:
Melanocytic activation (functional)- It involves an increased melanin synthesis and transfer from otherwise normal numbers of matrix melanocytes into the nail plate keratinocytes. Activation may be physiologic (racial/constitutional), hormonally mediated or reactive to local/systemic stimuli.
Melanocytic hyperplasia (proliferative)- It involves and increased number of melanocytes within the nail matrix epithelium (lentigo, melanocytic nevus) or neoplastic proliferation (subungual/NUM). Histopathology distinguishes activation (increased pigment without increased melanocyte density or atypia) from true hyperplasia.
Large clinicopathologic series and reviews estimate that the majority of LM cases are due to activation (often cited to be 50–75% depending on cohort), while a smaller fraction reflects true melanocytic hyperplasia. The reported malignant yield amongst biopsied longitudinal bands varies by referral population, but remains low overall. As reporting is heterogeneous, precise population-level proportions vary and are influenced by a referral bias (dermatology/oncology centres show higher malignant proportions).[1,20]
Genomic insights
Subungual (nail-unit) melanomas (SUM/NUM) share several molecular features with acral melanomas but also display distinct genomic profiles. Unlike sun-exposed cutaneous melanomas, SUMs show a markedly lower frequency of ultraviolet (UV)-associated BRAF mutations and a higher prevalence of structural genomic alterations, KIT mutations or amplifications and in some cohorts, GNAQ variants.[14,24,25] These findings indicate divergent oncogenic pathways and have therapeutic relevance – particularly the potential utility of KIT-directed therapy in selected cases.[14,24]
Recent sequencing data further highlights the unique molecular landscape of SUM. In a 2023 Asian cohort, 75% of SUMs were triple-wild-type (BRAF/NRAS/KIT-negative) but frequently harboured GNAQ R183Q (58%) and KIT mutations (25%); whereas acral melanomas in the same study more often showed BRAF (28.6%) or rat sarcoma (RAS) (14.3%) mutations. Unexpectedly, a UV-signature mutational pattern was also noted in SUM, suggesting a more complex biology than previously assumed.[14]
Other studies confirm the higher frequency of KIT alterations in acral melanomas and NUMs compared with sun-exposed melanomas and implicate GNAQ, GNA11 and SF3B1 mutations in subsets of acral or pigmented nail melanomas.[26-29]
However, Indian-specific genomic data remain scarce. For Indian patients, the clinical implications include:
Potential benefit from targeted therapy (e.g. imatinib for KIT-mutant tumours) and immunotherapy (anti-programmed cell death protein 1 [PD-1]/cytotoxic T-lymphocyte associated antigen 4 [CTLA-4]); although response rates in acral/nail melanomas may be lower than in conventional cutaneous melanoma.[30-34]
Need for routine molecular testing in confirmed SUM, especially in advanced or metastatic disease, to identify actionable mutations.[30]
Future Indian studies should incorporate comprehensive genomic profiling, focusing on the prevalence of KIT, GNAQ, NRAS, BRAF and other driver mutations to inform region-specific treatment strategies.
Activating and reactive causes
These could be physiologic or disease-related as follows.
Physiologic/constitutional causes
Racial/constitutional melanonychia: It is common in Fitzpatrick IV-VI skin and typically presents with multiple narrow, symmetric bands affecting several digits, often slowly widening with age (constitutional pattern). Distinguishing constitutional LM from early neoplasia requires attention to symmetry, stability and onychoscopic patterns.[35]
Hormonal states: Pregnancy and other endocrine changes can transiently activate matrix melanocytes, producing LM that may regress postpartum or after resolution of the trigger.[36]
Local/regional triggers
Trauma/chronic friction: Repeated microtrauma (tight footwear, sports, marching) can induce melanocytic activation in toenails, particularly the great toe. Trauma may also obscure early melanoma by producing a subungual haematoma or dystrophy.[37,38]
Habitual trauma: Nail-biting (onychotillomania) and other self-inflicted trauma may produce irregular streaks and matrix damage with reactive pigmentation.[39]
Inflammation/dermatoses: Chronic paronychia, lichen planus, psoriasis and other inflammatory conditions can cause melanocytic activation and longitudinal pigmentation.[40]
Infectious causes
Fungal melanonychia (FM): A recent systematic review (2024) confirms that a variety of melanised (dematiaceous) and some non-dematiaceous fungi (most commonly Trichophyton rubrum, Scytalidium spp. and dematiaceous moulds) can produce pigmented nail plates, clinically mimicking LM and occasionally leading to misdiagnosis. Onychoscopy and mycologic workup help differentiate FM from melanocytic causes. FM remains uncommon but is an important mimic, especially in regions with high prevalence of onychomycosis.[41]
Bacterial/exogenous pigments: Pseudomonas or Proteus infections and exogenous staining (henna, tar, nicotine) may cause distinctive green/black or distal/transverse discolouration that usually grows out with the plate and can be clinically distinguished in many cases.[42]
Systemic causes
Drug-induced causes
A range of medications (minocycline, zidovudine, chemotherapeutic agents, antimalarials, some psychotropics) can cause diffuse or LM through activation or deposition; temporal correlation with drug exposure is usually diagnostic.[45-48]
Proliferative causes (non-neoplastic)
Benign nevi/lentigo: Nail-matrix nevi and lentiginous proliferation (often in younger adults) produce focal melanocytic hyperplasia and usually demonstrate regular onychoscopic lines and benign histology. Careful clinicopathologic correlation is required as nevi can show atypia in small biopsies.[49]
Other tumours: Non-melanocytic nail-unit tumours (onychomatricoma, Bowen’s disease, squamous cell carcinoma, keratoacanthoma) may secondarily produce nail discolouration and should be included in the differential diagnosis. Histopathology and targeted imaging/biopsy clarify the diagnosis.[50,51]
CLINICAL FEATURES
Adult-onset LM may present with various clinical patterns [Figure 1a-c]. A vertical band extending from the proximal fold to the free edge of the nail plate is the most common presentation as well as the most concerning when noticed on a single digit in an adult. Total (diffuse) melanonychia involves an entire nail plate becoming pigmented. Polydactylous total melanonychia is typically associated with systemic causes, whereas monodactylous involvement raises concern for localised pathology, including advanced melanoma.[35,43,44] Transverse melanonychia is uncommon and most frequently drug-induced.[1,48]

- Different types of adult-onset melanonychia. (a) Light brown coloured band of recent onset, involving 4 nails in a 32-year-old male, suggestive of melanocyte activation. (b) Dark coloured band involving a single nail in a 25-year-old female. Progressively darkening for the past 2 years, suggestive of melanocyte proliferation. (c) Broad dark band with progressive colour variegation in a 35-year-old male, arousing suspicion of a malignancy.
Recognition of red flags in LM is essential for early diagnosis. Benign bands are typically narrow, uniform in colour, stable over time and often involve multiple nails. In contrast, features that raise concern for SUM/NUM include solitary digit involvement (particularly the thumb or great toe), band width exceeding 3 mm, irregular or blurred borders, variegated pigmentation and any rapid change in width or colour. Additional warning signs are the presence of Hutchinson’s sign (pigment extending onto the proximal or lateral nail fold or hyponychium), along with nail plate dystrophy, fissuring, ulceration or bleeding. A personal or family history of melanoma further increases suspicion [Table 1].[1,3,35] These clinical parameters should be routinely elicited during history and assessed carefully on examination. While the ABCDE rule remains the cornerstone for identifying suspicious cutaneous melanocytic lesions, it does not fully capture the unique presentations of NUM.[52] To address these differences, the ABCDEF rule was explicitly developed for NUM, incorporating additional parameters such as digit involvement, periungual extension and patient risk factors [Table 2].[5,53,54] A photographic documentation at baseline and during follow-up (every 3–6 months) is strongly recommended for melanonychia, especially LM.[9]
| Feature | Benign LM | Worrisome LM (high-risk features suggestive of NUM) |
|---|---|---|
| Number of nails | Often multiple nails involved (common in ethnic/racial LM, systemic causes). | Usually a solitary digit, especially thumb or great toe. |
| Band width | Typically, a narrow band (<3 mm). | Width >3 mm, broad band or occupying >1/3 of nail plate. |
| Colour | Uniform, light-to medium-brown. | Variegate pigmentation (brown, black, grey) or heterogeneous colour pattern. |
| Borders | Regular, smooth, parallel edges. | Irregular borders, blurred or uneven margins. |
| Evolution over time | Stablein width and colour. | Rapid increase in width, darkening or new streaking. |
| Periungual pigmentation | None or pseudo-Hutchinson’s sign (visible pigment through translucent cuticle). | True Hutchinson’s sign: pigment extension onto the proximal/lateral nail fold or hyponychium. |
| Nail plate changes | Usually normal; no structural abnormalities. | Nail dystrophy, fissuring, splitting, ulceration or bleeding. |
| History | No risk factors. | Personal or family history of melanoma or dysplastic nevi. |
NUM: Nail unit melanoma, LM: Longitudinal melanonychia
| ABCDE rule for cutaneous melanoma | ABCDEF rule for subungual melanoma |
|---|---|
| A - Asymmetry: One half of the lesion does not match the other. | A - Age/race: Peak incidence in the 5th–7thdecade; more common in darker skin types. |
| B - Border: Irregular, scalloped or poorly defined edges. | B - Brown/black band: Pigmented band ≥3 mm with irregular borders. |
| C - Colour: Variation in colour (brown, black, red, white, blue). | C - Change: Rapid increase in width of the band or change in nail pigmentation. |
| D - Diameter: >6 mm is concerning, though smaller lesions can be melanoma. | D - Digit: Most often involves thumb, great toe or single digit involvement. |
| E - Evolving: Any change in size, shape, colour or symptoms. | E - Extension: Pigment spread to proximal or lateral nail folds (Hutchinson’s sign). |
| *F- Firm (Applicable only for nodular melanoma as a part of EFG rule (E- elevated & G- growing)) | F - Family/personal history: History of melanoma or dysplastic nevi increases suspicion. |
Hutchinson’s sign (HS)
Periungual pigmentation, traditionally termed HS, originates from Hutchinson’s 1886 description of ‘melanotic whitlow’ associated with nail melanoma.[55] Over the years, HS has been considered an important warning sign for SUM; yet its use has often been inconsistent, contributing to its clinical ambiguity. HS is a visible clinical finding, defined as melanin pigmentation on any periungual structure, which should prompt careful evaluation for melanoma [Figure 2a]. Notably, HS may occur in both benign and malignant melanocytic nail lesions.

- Onychoscopy of longitudinal melanonychia in adult patients. (a) Light brown to grey band with regular edges. Suggestive of melanocyte hyperplasia. (b) Black band with regular edges and peripheral pigment granules, suggestive of melanocyte proliferation (Polarised ×50).
Pseudo-HS refers to pigmentation visible through the translucent cuticle or proximal nail fold [Figure 2b], while micro-HS denotes subtle periungual pigmentation detectable only on close inspection or onychoscopy. Because periungual pigmentation alone cannot reliably distinguish benign from malignant causes, nail matrix biopsy remains essential for diagnosis in adults. Although descriptive terminology has been proposed, retaining the eponym ‘Hutchinson sign’ is helpful because it alerts clinicians to the possibility of melanoma.[56] In patients with skin of colour, in whom physiological or racial melanonychia is highly prevalent, benign, faint pigmentation on the nail folds is common. It represents normal melanocyte activation and is not associated with melanoma, affirming that the HS is not pathognomonic for SUM, and its specificity is significantly limited, especially in individuals with skin of colour.
ONYCHOSCOPY
Onychoscopy is an indispensable tool in evaluating pigmented nail bands and guiding biopsy decisions.[57] Recognition of onychoscopic patterns is crucial for distinguishing benign LM from NUM, particularly in adults presenting with new or changing nail pigmentation. Onychoscopy enhances diagnostic accuracy by allowing detailed assessment of band colour, line regularity, parallelism and periungual pigmentation [Figure 3a-c] – features that often reveal early malignant change before overt clinical signs appear. While benign LM typically demonstrates stable, homogeneous and orderly patterns, NUM is characterised by asymmetry, irregularity and progressive evolution. A comparative summary of key benign versus malignant onychoscopic findings is presented in Table 3.[57-59]

- Hutchinson’s sign and its variants. (a) Hutchinson’s sign, seen as a peripheral spread of pigment in the proximal nail fold, in a 22-year-old female. (b) Pseudo-Hutchinson’s sign in a 5-year-old boy. The pigmented band is seen through a transparent cuticle and proximal nail fold. (c) Micro-Hutchinson’s sign on onychoscopy showing pigment spread in the distal nail fold, which was invisible on naked eye examination (Polarised ×50).
| Onychoscopic feature | Benign longitudinal melanonychia | Nail unit melanoma (Malignant LM) |
|---|---|---|
| Band colour | Homogeneous light-medium brown; uniform colour | Variegated colours: Brown, black, grey; heterogeneous pigmentation |
| Band width | Usually narrow; stableover time | Broad band>3 mm; progressive widening; triangular sign (wider proximally) |
| Parallelism | Regular, parallel longitudinal lines | Irregular, non-parallel lines; asymmetry in thickness and spacing |
| Borders/edges | Sharp, well-defined, smooth borders | Blurred, irregular, fuzzy or notched borders |
| Pigment distribution | Uniform along the entire length | Irregular, discontinuous or blotchy pigmentation with loss of homogeneity |
| Micro-Hutchinson’s sign | Rare | May be present – subtle periungual pigmentation on dermoscopy |
| True Hutchinson’s sign | Rare | Present in many cases – pigment extends onto proximal/lateral nail folds or hyponychium |
| Nail plate changes | Generally normal nail plate | Dystrophy, fissuring, splitting, ridging, ulceration or bleeding |
| Number of nails | Often multiple (ethnic LM, drug-induced) | Usually a solitary digit (especially thumb or great toe) |
| Temporal changes | Stableover years | Rapid change in width, colour or pattern |
| Pattern specificity | Regular lines with consistent colour spacing | Irregular lines (‘chaotic pattern’), pseudo-granular pigmentation, blurred micro-streaks |
| Associated features | Absent | Nail fold pigmentation, periungual pigmentation, subungual hyperkeratosis |
NUM: Nail-unit melanoma, LM: Longitudinal melanonychia
Onychoscopic examination is widely considered the standard-of-care worldwide and can help provide early pointers towards possible malignancy. Its role in the follow-up of these patients is also important. In a Korean series of 8 SUM in situ adult patients, all had presented with a solitary LM with periungual pigmentation in 87.5% cases, along with a pigmented background. As per the authors, the ‘nail ABCD’ rule (Adult age, Brown band in brown background, Colour in periungual skin, single Digit) achieved 100% sensitivity and 96.6% specificity in their series.[23]
Intra-operative onychoscopy (after removing nail plate) is also useful [Figure 4]. Although operationally difficult, it may show regular parallel matrix pigmentation in benign cases. However, in melanoma, irregular dark structures have been described.[60]

- Intra-operative onychoscopy showing regular pigment with defined margins as the matrix origin of a longitudinal pigmented band (Polarised ×50).
DIAGNOSIS
As outlined above, a detailed history is essential including the age at onset, duration, changes in width/colour, pain/ bleeding, history of trauma, footwear, microtrauma, medications, systemic symptoms (adrenal, endocrine) and family/personal melanoma history. Examination requires review of all nails (fingers and toes) including the number of nails involved, band colour/width, presence of HS or its variants, nail plate changes, symmetry, and condition of adjacent skin/mucosa.[1-3] If systemic causes are suspected (e.g. adrenal disease, nutritional deficiency), targeted laboratories may include serum cortisol, adrenal panel, B12 levels, iron studies and HIV, as indicated.[1] If the setting suggests so, FM may be ruled out based on relevant tests.
Any adult with LM showing red-flag features should prompt a nail matrix biopsy. This is especially important in cases where follow-up is not possible. Partial techniques (punch biopsy or incisional biopsy) have a high risk of sampling error; hence, ‘en bloc’ excision of the nail-matrix origin of the band is needed to capture the radial growth phase and any vertical invasion. In pigmented skin types, the threshold for biopsy should be kept low, due to a higher background incidence of benign bands and greater risk of overlooking melanoma.[1-3,9]
Surgical techniques require removal of the overlying nail plate to expose the matrix origin of the band (the darkest pigmented zone). Adequate sampling of the matrix origin (in toto) is important.[4] In this regard, tangential excision is very helpful. It is a minimally invasive technique recommended for sampling pigmented nail matrix lesions, particularly those causing LM. This approach allows for sufficient pathological assessment, while minimising the risk of permanent nail plate dystrophy. The procedure involves lifting the proximal nail fold to expose the matrix and removing a thin, superficial layer containing the pigment band origin [Figure 5a-e]. This technique is especially suited for bands wider than 4 mm and is favoured for ruling out melanoma with less post-operative morbidity than full-thickness excision.[61,62] Pre- and post-operative nail-unit care is essential to minimise dystrophy.

- Tangential nail matrix biopsy in a case with adult-onset melanonychia. (a) Exposing the matrix origin of the band by retracting the proximal nail fold (held back with stay sutures) and proximal partial avulsion of the nail plate. (b) The matrix melanotic origin is completely defined and then tangentially excised with the blade kept horizontal to the matrix surface. (c) The defect in the matrix as well as the excised melanotic lesion (placed on the gloved finger) can be seen. (d) No trace of melanin in the matrix. (e) The proximal nail fold is released to its original position and sutured on both sides. The sutures can be removed after a week.
Histopathology and clinicopathologic correlation
Histopathology of the nail matrix remains the gold standard for diagnosis. In cases with melanocyte proliferation it may show any of the following features
Benign nevi/lentigines: Symmetrical lentiginous proliferation or nests of melanocytes with minimal atypia, no pagetoid spread, no dermal invasion.[4,9]
Melanoma in situ: Atypical lentiginous proliferation, scattered atypical melanocytes with hyperchromatic nuclei, possible pagetoid upwards scatter, but no dermal invasion.[7-9]
Invasive melanoma: Dermal invasion by atypical melanocytes, mitoses, deep nesting, lymphovascular invasion, asymmetry and poor circumscription.[7-9]
Immunohistochemistry [Melan-A, human melanoma black 45 (HMB45), sex-determining region Y-related high mobility group-box transcription factor 10 (SOX10), preferentially expressed antigen in melanoma (PRAME)] assists the identification of melanocyte proliferation. Equivocal diagnoses such as ‘atypical melanocytic hyperplasia’ require close clinicopathologic correlation and often repeat biopsy if suspicion persists.[4]
Emerging histopathologic markers: Cellular remnants of melanocytes (CRMs)
Large CRMs within the nail plate have recently been recognised as a valuable diagnostic marker for distinguishing SUM from benign melanocytic proliferations such as nail matrix nevi (NMN). CRMs are detectable only when the nail plate is included in the biopsy specimen. They result from transepithelial elimination of melanocytes from the nail matrix – a phenomenon particularly pronounced in SUM due to its characteristic single-cell (pagetoid) upwards migration. Histologically, CRMs are categorised into three patterns: Type I (CRMs showing retraction artefact with partial pigmentation), Type II (Heavily pigmented CRMs without retraction artefact) and Type III (CRMs demonstrating retraction artefact and nuclear remnants). SUM specimens exhibit a significantly higher number and greater linear density of CRMs compared with NMN, along with a more dorsally distributed pattern within the nail plate. This reflects the infiltrative and vertically spreading behaviour of melanoma cells in the nail matrix. Immunohistochemistry (HMB-45 and S-100) can assist in confirming the melanocytic origin of these remnants, although melan-A may be variably expressed because of processing-related artefacts. The presence of numerous CRMs – particularly types I and III – and their widespread dorsal distribution strongly favour a diagnosis of SUM. Importantly, the nail plate should be submitted for histopathological evaluation whenever available, as clinicopathologic correlation greatly enhances diagnostic accuracy.[63-65]
In SUM, clinicopathologic correlation is crucial with respect to lesion width, onychoscopic features, digital site and HS and matrix histology should all align before excluding malignancy.
APPROACH TO MELANONYCHIA IN INDIAN ADULT PATIENTS
Table 1 summarises the key features to be evaluated, and findings suggesting benign vs malignant potential in Indian skin. It is intended as a clinical decision aid and not a substitute for biopsy. Any high-risk feature should always prompt a nail matrix biopsy histologic evaluation, which remains the diagnostic gold standard. This is especially important in adult patients in whom follow-up cannot be ensured.
In an adult patient presenting with a recent onset of LM, or a recently expanding band of melanonychia, apart from a detailed history, examination of all 20 nails is mandatory. It should include inspection of all fingers and toes, band width/ colour/border, peri- or lateral fold pigment (HS) or any signs of nail dystrophy. Onychoscopy is essential to evaluate the line pattern, thickness/spacing, background colour and periungual involvement. Baseline photographs (both clinical and onychoscopic) are essential, especially in the scenario where a decision is taken to keep the patient under follow-up.
Assessment of the cause is important. If multiple nails are involved with narrow uniform bands that are stable, it is likely benign (constitutional/reactive). Such cases can be observed with serial onychoscopy every 3–6 months. However, if a solitary digit is involved with a band >3 mm in width, irregular lines/colour, HS, or rapidly changing morphology, it suggests high-risk. With any of these signs, it would be prudent to proceed with nail matrix biopsy from the origin of the band. Partial punch biopsy may suffice only for low-risk cases, but close follow-up is then required.
Thereafter, based on the histologic diagnosis, benign bands may be followed up. Lentigo or nevi require monitoring of the evolution of the band. They may resolve if the excision has been total. Cases diagnosed with dysplasia or melanoma require appropriate treatment [Figure 6]. Surgical management (functional surgery if possible), possible sentinel node staging, adjuvant therapy and surveillance every 3–6 months initially, is required. In Indians, the threshold for biopsy may be higher than in white-skin, given the higher background prevalence of pigmented nails.

- Structured diagnostic algorithm for adult-onset melanonychia in Indian patients.
MANAGEMENT STRATEGIES
For adult-onset melanonychia, management is dictated entirely by the underlying histopathologic diagnosis.
Management of benign adult-onset melanonychia
For melanonychia diagnosed as benign (e.g., constitutional/ racial LM, drug-induced, lentigo, or melanocytic nevus):
Reassurance and documentation: No specific medical therapy is required. The patient should be reassured of the benign nature of the lesion. The band must be documented with baseline photography and onychoscopy.
Monitoring: The lesion should be followed up on every 3–6 months to ensure stability. Any change in width, colour or pattern necessitates re-evaluation and potential biopsy.
Causative trigger treatment: If a reactive or systemic cause is identified, it should be managed to avoid the underlying trigger. Treatment of infections, especially fungal (FM) or bacterial causes, may help resolution. Discontinuation or substitution of any offending drug (if feasible) helps in resolution. For systemic disease, referral to a specialist (e.g. endocrinologist for Addison’s disease, haematologist for B12 deficiency) is required.
Benign nevus/lentigo: If the lesion was excised entirely during the biopsy (e.g. a small nevus removed by tangential excision), the pigmentation may resolve. If not, monitoring (as above) is required.[1-3]
Management of SUM in situ
For non-invasive disease (Melanoma in situ):
The primary treatment is surgical excision of the entire nail matrix lesion, aiming for clear margins.
Efforts should be made to perform functional, tissue-sparing surgery, preserving the distal phalanx if clear margins can be achieved. Nail-unit reconstruction may follow.
Achieving clear surgical margins is essential to prevent recurrence.[9,20,66,67]
Management of invasive SUM
For invasive disease (Melanoma Breslow depth > 0 mm):
Treatment involves wide local excision of the primary tumour. Current guidelines favour tissue-sparing excision over historical amputation of the distal phalanx when negative margins can be achieved without amputation. Surgical margins are guided by the Breslow depth, similar to cutaneous melanoma.
Sentinel lymph node biopsy (SLNB) is considered for lesions ≥ 1mm in Breslow depth or thinner lesions with high-risk features (e.g. ulceration, high mitotic rate).
Routine molecular testing and profiling is crucial to identify actionable mutations, particularly in advanced or metastatic disease. In Asian populations, testing should focus on KIT, GNAQ, NRAS and BRAF mutations.
Adjuvant systemic therapy may be considered. Targeted therapy may be used if an actionable mutation is identified (e.g. imatinib for KIT-mutant tumours). Immunotherapy with immune checkpoint inhibitors (e.g. anti-PD-1/CTLA-4) is standard for high-risk invasive disease, although response rates in acral/nail melanoma may be lower than in conventional cutaneous melanoma.
Lifelong surveillance is essential. Regular clinical and onychoscopic review is needed every 3–6 months (for the first 2 years), then annually. Patients must be educated on nail self-checks and prompt review of any recurrence or new pigmented nail lesions.[9,20,66,67]
PROGNOSIS
The prognosis of adult-onset melanonychia depends on the underlying aetiology. Benign bands carry no specific morbidity apart from cosmetic impact. In SUM, prognosis is stage-dependent. Early (in situ or thin invasive) lesions have favourable outcomes, whereas delayed-stage disease (nodal or distant metastases) carries poor survival. Notably, some studies suggest that SUM may have better overall survival than other acral melanomas, possibly reflecting biological differences, though diagnostic delay remains a key adverse factor. In an Indian case series, metastases were found at presentation in half of the patients. This underscores the negative impact of delayed diagnosis.[3] Early recognition is critical to improving outcomes.[1-3,11,20,66,67]
CONCLUSION AND FUTURE DIRECTIONS
In Indian patients, adult-onset melanonychia is most frequently benign, reflecting ethnic pigmentation or non-malignant causes. It often requires reassurance and monitoring only. Nonetheless, clinicians must maintain vigilance for SUM, especially when red-flag clinical or onychoscopic features are present. A structured assessment algorithm, incorporating history, full-nail examination, dermoscopy, baseline photography and timely biopsy, provides a pragmatic path to early detection. Emerging molecular data (notably KIT and GNAQ mutations in SUM) highlight that NUM may represent a biologically distinct entity compared to sun-exposed cutaneous melanoma; however, Indian-specific molecular data are lacking. Further research in India on prevalence, onychoscopic patterns, histopathologic correlates and genetic drivers of nail-unit melanonychia and melanoma is strongly needed. Given the cultural and resource-related factors that may delay diagnosis (reluctance for biopsy, nail-cosmetic concerns, misdiagnosis as fungal infection/trauma), increasing clinician awareness, improving access to dermoscopy and judicious use of biopsy in suspicious cases will help shift outcomes favourably.
Authors’ contributions:
Dinesh Mathur: Concepts, design, definition of intellectual content, literature search, data acquisition, data analysis, manuscript preparation, manuscript editing, manuscript review. Vishal Gaurav: Concepts, design, definition of intellectual content, literature search, data acquisition, data analysis, manuscript preparation, manuscript editing, manuscript review, guarantor. Chander Grover: Concepts, design, definition of intellectual content, literature search, data acquisition, data analysis, manuscript preparation, manuscript editing, manuscript review, data analysis.
Ethical approval:
Institutional review board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest:
All three authors are on the editorial board of the Journal.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Melanonychia: Etiology, diagnosis, and treatment. Indian Dermatol Online J. 2020;11:1-11.
- [CrossRef] [PubMed] [Google Scholar]
- Diagnosis and management of nail pigmentations. J Am Acad Dermatol. 2007;56:835-47.
- [CrossRef] [PubMed] [Google Scholar]
- Basic approach to melanonychia-a review. Int J Res Dermatol. 2022;8:426-32.
- [CrossRef] [Google Scholar]
- Pigmented lesions of the nail unit: Clinical and histopathologic features. Semin Cutan Med Surg. 2010;29:148-58.
- [CrossRef] [PubMed] [Google Scholar]
- Acral lentiginous melanoma: A clinicoprognostic study of 126 cases. Br J Dermatol. 2006;155:561-9.
- [CrossRef] [PubMed] [Google Scholar]
- Acral cutaneous melanoma in caucasians: Clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143:275-80.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas. Melanoma Res. 2020;30:562-73.
- [CrossRef] [PubMed] [Google Scholar]
- Evaluation and diagnosis of longitudinal melanonychia: A clinical review by a nail expert group. J Am Acad Dermatol. 2025;93:176-87.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical and dermoscopic findings of benign longitudinal melanonychia due to melanocytic activation differ by skin type and predict likelihood of nail matrix biopsy. J Am Acad Dermatol. 2022;87:792-9.
- [CrossRef] [PubMed] [Google Scholar]
- Subungual melanoma is not so rare: Report of four cases from India. Indian Dermatol Online J. 2017;8:471-4.
- [CrossRef] [PubMed] [Google Scholar]
- Acral melanoma in skin of color: Current insights and future directions: A narrative review. Cancers (Basel). 2025;17:468.
- [CrossRef] [PubMed] [Google Scholar]
- Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138:1327-33.
- [CrossRef] [PubMed] [Google Scholar]
- Differences in the clinical and molecular profiles of subungual melanoma and acral melanoma in Asian patients. Cancers (Basel). 2023;15:4417.
- [CrossRef] [PubMed] [Google Scholar]
- Molecular profile of subungual melanoma: A melanostrum consortium study of 68 cases reporting BRAF, NRAS, KIT, and TERT promoter status. Dermatology. 2024;240:164-9.
- [CrossRef] [PubMed] [Google Scholar]
- Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545:175-80.
- [CrossRef] [PubMed] [Google Scholar]
- Dealing with melanonychia. Semin Cutan Med Surg. 2009;28:49-54.
- [CrossRef] [PubMed] [Google Scholar]
- Melanocytic lesions of the nail unit. Dermatopathology (Basel). 2018;5:98-107.
- [CrossRef] [PubMed] [Google Scholar]
- Nail apparatus melanoma: Current management and future perspectives. J Clin Med. 2023;12:2203.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical characteristics of nail unit melanoma in Türkiye: The experience of two tertiary dermatology centers. Balkan Med J. 2025;42:157-63.
- [CrossRef] [PubMed] [Google Scholar]
- Benign longitudinal melanonychia in skin of colour: A case series. J Onychol Nail Surg. 2025;2:37-40.
- [CrossRef] [Google Scholar]
- Early detection of subungual melanoma in situ: Proposal of ABCD strategy in clinical practice based on case series. Ann Dermatol. 2018;30:36-40.
- [CrossRef] [PubMed] [Google Scholar]
- Adult and pediatric nail unit melanoma: Epidemiology, diagnosis, and treatment. Cells. 2023;12:964.
- [CrossRef] [PubMed] [Google Scholar]
- Mutation profile of primary subungual melanomas in Caucasians. Oncotarget. 2020;11:2404-13.
- [CrossRef] [PubMed] [Google Scholar]
- Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure. Pigment Cell Melanoma Res. 2010;23:210-5.
- [CrossRef] [PubMed] [Google Scholar]
- Analysis of KIT expression and gene mutation in human acral melanoma: With a comparison between primary tumors and corresponding metastases/recurrences. Hum Pathol. 2013;44:1472-8.
- [CrossRef] [PubMed] [Google Scholar]
- Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum. Pigment Cell Melanoma Res. 2016;29:470-3.
- [CrossRef] [PubMed] [Google Scholar]
- Subungual melanoma with blue naevus-like morphological features: A clinicopathological retrospective analysis of nine cases. Pathology. 2022;54:541-7.
- [CrossRef] [PubMed] [Google Scholar]
- Management of advanced melanoma in the current era: A medical oncology perspective for the Indian scenario. Natl Med J India. 2020;33:89-98.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT. Br J Cancer. 2010;102:1219-23.
- [CrossRef] [PubMed] [Google Scholar]
- Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol. 2013;31:3182-90.
- [CrossRef] [PubMed] [Google Scholar]
- Immunotherapy in Acral and mucosal melanoma: Current status and future directions. Front Immunol. 2021;12:680407.
- [CrossRef] [PubMed] [Google Scholar]
- Immune checkpoint inhibitors in advanced acral melanoma: A systematic review. Front Oncol. 2020;10:602705.
- [CrossRef] [PubMed] [Google Scholar]
- Melanonychia striata: Clarifying behind the black curtain. A review on clinical evaluation and management of the 21st century. Int J Dermatol. 2019;58:1239-45.
- [CrossRef] [PubMed] [Google Scholar]
- Subungual nail pigmentation and malalignment of the great toe nail in a cancer patient-a diagnostic challenge. Open Access Maced J Med Sci. 2017;5:467-9.
- [CrossRef] [PubMed] [Google Scholar]
- Missed opportunity to diagnose subungual melanoma: Potential pitfalls! BMJ Case Rep. 2017;2017:bcr2016218785.
- [CrossRef] [PubMed] [Google Scholar]
- Onychotillomania: A chameleon-like disorder: case report and review of literature. Skin Appendage Disord. 2019;5:104-7.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical characteristics and management outcomes in isolated nail lichen planus: A retrospective case series. Indian J Dermatol Venereol Leprol. 2024;90:329-35.
- [CrossRef] [PubMed] [Google Scholar]
- Fungal melanonychia: A systematic review. Microorganisms. 2024;12:1096.
- [CrossRef] [PubMed] [Google Scholar]
- Melanonychia: A challenging green nail syndrome case report. Clin Case Rep. 2025;13:e70723.
- [CrossRef] [PubMed] [Google Scholar]
- Addisonian pigmentation-the great mimicker-a review. Indian J Dermatol. 2024;69:422.
- [CrossRef] [PubMed] [Google Scholar]
- Total melanonychia of 20 nails as a rare manifestation of vitamin B12 deficiency. JAAD Case Rep. 2020;6:372-3.
- [CrossRef] [PubMed] [Google Scholar]
- Narrative review of drug-associated nail toxicities in oncologic patients. Dermatol Pract Concept. 2023;13:e2023064.
- [CrossRef] [PubMed] [Google Scholar]
- Paclitaxel-induced periarticular thenar erythema with onycholysis syndrome. Skin Appendage Disord. 2024;10:74-7.
- [CrossRef] [PubMed] [Google Scholar]
- Paclitaxel-induced nail changes with palmoplantar erythrodysesthesia. CosmoDerma. 2023;3:185.
- [CrossRef] [Google Scholar]
- Dasatinib-induced transverse melanonychia. Skin Appendage Disord. 2023;9:449-52.
- [CrossRef] [PubMed] [Google Scholar]
- A review of the histopathology of nail unit tumors including selection of the optimal surgical sampling. Skin Appendage Disord. 2024;10(6):443-58.
- [CrossRef] [PubMed] [Google Scholar]
- Differential diagnosis of pigmented nail lesions. An Bras Dermatol. 2024;99:799-814.
- [CrossRef] [PubMed] [Google Scholar]
- Pigmented onychomatricoma presenting as pachymelanonychia striata: A case report and review of literature. Skin Appendage Disord. 2023;9:366-72.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical ABCDE rule for early melanoma detection. Eur J Dermatol. 2021;31:771-8.
- [CrossRef] [PubMed] [Google Scholar]
- The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000;42:269-74.
- [CrossRef] [PubMed] [Google Scholar]
- A narrative review of the evolution of diagnostic techniques and treatment strategies for acral lentiginous melanoma. Int J Mol Sci. 2024;25:10414.
- [CrossRef] [PubMed] [Google Scholar]
- Melanosis often not black: Melanotic whitlow. Br Med J. 1886;1:491.
- [CrossRef] [PubMed] [Google Scholar]
- Modern definitions of periungual pigmentation (Hutchinson sign): Results of an expert opinion consensus conference. J Am Acad Dermatol 2025 [Article in Press]
- [CrossRef] [Google Scholar]
- Use of Nail dermoscopy in the management of melanonychia: Review. Dermatol Pract Concept. 2019;9:38-43.
- [CrossRef] [PubMed] [Google Scholar]
- Longitudinal melanonychia: How to distinguish a malignant condition from a benign one. Chin J Plast Reconstr Surg. 2021;3:56-62.
- [CrossRef] [Google Scholar]
- Dermoscopy of melanoma according to different body sites: Head and neck, trunk, limbs, nail, mucosal and acral. J Eur Acad Dermatol Venereol. 2023;37:1718-30.
- [CrossRef] [PubMed] [Google Scholar]
- Intra-operative dermoscopy (onychoscopy) of the nail unit-a systematic review. J Eur Acad Dermatol Venereol. 2024;38:1988-96.
- [CrossRef] [PubMed] [Google Scholar]
- Tangential excision of pigmented nail matrix lesions responsible for longitudinal melanonychia: Evaluation of the technique on a series of 30 patients. J Am Acad Dermatol. 2013;69:96-104.
- [CrossRef] [PubMed] [Google Scholar]
- Distribution of cellular remnants of melanocytes in the nail plate: Clue to the diagnosis of subungual melanoma. J Cutan Pathol. 2022;49:331-7.
- [CrossRef] [PubMed] [Google Scholar]
- Evaluation of large cellular remnants of melanocytes in the nail plate: An advancement in the correlation of diagnosis and prognosis for nail unit melanocytic lesions. J Cutan Pathol. 2022;49:418-9.
- [CrossRef] [PubMed] [Google Scholar]
- A call for nail clipping histopathology to become an essential component of the routine evaluation of melanonychia: Benefitting patients as a triage and surgical planning maneuver. J Cutan Pathol. 2023;50:279-83.
- [CrossRef] [PubMed] [Google Scholar]
- Subungual melanoma: Management in the modern era. J Plast Reconstr Aesthet Surg. 2017;70:1746-52.
- [CrossRef] [PubMed] [Google Scholar]
- Surgical excision methods for skin cancer involving the nail unit: A systematic review. Cochrane Evid Synth Methods. 2023;1:e12026.
- [CrossRef] [PubMed] [Google Scholar]

